FDAFDA · Food and drugs·Recall number D-0107-2018
Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, Inc. Northvale, NJ 07647, NDC 42806-263-01, UPC 342806263013
Published December 13, 2017 · Recall initiated: November 13, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Manufacturer
- Elite Laboratories Inc.
- Distributor
- NY only
- Lot
- Lot #: P0910-017, Exp. 05/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.